Phenotyping patients with ischaemic heart disease at risk of developing heart failure: an analysis of the HOMAGE trial

Phenotyping patients with ischaemic heart disease at risk of developing heart failure: an analysis of the HOMAGE trial

Abstract Aims We aim to characterize the clinical and proteomic profiles of patients at risk of developing heart failure (HF), with and without coronary artery disease (CAD) or prior myocardial infarction (MI). Methods and results HOMAGE evaluated the effect of spironolactone on plasma and serum mar...

Full description

Bibliographic Details
Main Authors: Diogo Santos‐Ferreira, Sílvia O. Diaz, João Pedro Ferreira, Nicolas Girerd, Pierpaolo Pellicori, Beatrice Mariottoni, Franco Cosmi, Mark Hazebroek, Job A.J. Verdonschot, Joe Cuthbert, Johannes Petutschnigg, Stephane Heymans, Jan A. Staessen, Burkert Pieske, Frank Edelmann, Andrew L. Clark, Patrick Rossignol, Ricardo Fontes‐Carvalho, John G.F. Cleland, Faiez Zannad
Format: Article
Language:English
Published: Wiley 2024-02-01
Series:ESC Heart Failure
Subjects:
Coronary artery disease
Heart failure
Myocardial infarction
Proteomics
Spironolactone
Online Access:https://doi.org/10.1002/ehf2.14465

Similar Items

Similar Items